Aclarion, Inc. (ACONW)
ACONW Stock Price Chart
Explore Aclarion, Inc. interactive price chart. Choose custom timeframes to analyze ACONW price movements and trends.
ACONW Company Profile
Discover essential business fundamentals and corporate details for Aclarion, Inc. (ACONW) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
22 Apr 2022
Employees
5.00
Website
https://www.aclarion.comCEO
Brent Ness
Description
Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S. market. Its flagship product is the NOCISCAN-LS Post-Processor suite. This comprehensive suite includes NOCICALC-LS, which processes magnetic resonance spectroscopy (MRS) data from spinal discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a vital clinical decision support tool. Initially named Nocimed, Inc., the company adopted the Aclarion, Inc. moniker in December 2021. Established in 2008, Aclarion, Inc. maintains its headquarters in San Mateo, California.
ACONW Financial Timeline
Browse a chronological timeline of Aclarion, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Aug 2026
EPS estimate is -$1.05, while revenue estimate is $30.00k.
Earnings released on 13 May 2026
EPS came in at -$1.34 matching the estimated -$1.34, while revenue for the quarter reached $20.00k , meeting expectations.
Earnings released on 25 Feb 2026
EPS came in at -$3.60 matching the estimated -$3.60, while revenue for the quarter reached $20.00k , meeting expectations.
Earnings released on 12 Nov 2025
EPS came in at -$2.93 surpassing the estimated -$2.93 by 0.00%, while revenue for the quarter reached $18.94k , missing expectations by -0.31%.
Earnings released on 14 Aug 2025
EPS came in at -$2.75 falling short of the estimated -$2.26 by -21.62%, while revenue for the quarter reached $19.32k , missing expectations by -35.60%.
Earnings released on 15 May 2025
EPS came in at -$9.29 surpassing the estimated -$452.25 by +97.95%, while revenue for the quarter reached $18.99k , missing expectations by -5.05%.
Earnings released on 9 Apr 2025
EPS came in at -$1.55k falling short of the estimated -$1.13k by -37.26%, while revenue for the quarter reached $10.23k , missing expectations by -41.53%.
Earnings released on 14 Nov 2024
EPS came in at -$1.31k surpassing the estimated -$1.40k by +6.57%, while revenue for the quarter reached $14.41k , missing expectations by -3.95%.
Earnings released on 14 Aug 2024
EPS came in at -$1.36k falling short of the estimated -$1.36k by -0.45%, while revenue for the quarter reached $10.97k , beating expectations by +4.49%.
Earnings released on 15 May 2024
EPS came in at -$3.99k falling short of the estimated -$3.98k by -0.18%, while revenue for the quarter reached $10.11k , beating expectations by +1.14%.
Earnings released on 28 Mar 2024
EPS came in at -$13.87k surpassing the estimated -$14.47k by +4.19%, while revenue for the quarter reached $13.80k , missing expectations by -90.80%.
Earnings released on 14 Nov 2023
EPS came in at -$16.94k falling short of the estimated -$13.02k by -30.05%, while revenue for the quarter reached $19.07k , missing expectations by -74.58%.
Earnings released on 25 Aug 2023
EPS came in at -$25.57k falling short of the estimated -$13.02k by -96.35%, while revenue for the quarter reached $17.07k , missing expectations by -65.86%.
Earnings released on 3 Jul 2023
EPS came in at -$21.57k , while revenue for the quarter reached $25.47k .
Earnings released on 31 Dec 2022
EPS came in at -$24.50k , while revenue for the quarter reached $22.52k .
Earnings released on 15 Aug 2022
EPS came in at -$93.43k , while revenue for the quarter reached $10.68k .
Earnings released on 6 Jun 2022
EPS came in at -$20.34k , while revenue for the quarter reached $9.03k .
Earnings released on 31 Dec 2021
EPS came in at -$63.21k , while revenue for the quarter reached $11.98k .
Earnings released on 30 Sept 2021
EPS came in at -$471.77k , while revenue for the quarter reached $10.87k .
ACONW Stock Performance
Access detailed ACONW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
